Highlights:,Cologuard Plus™ outperforms other noninvasive screening ... sed do eiusmod tempor incididunt ut labore et dolore ...

"The discussion on the call focused ad nauseam about levers to ... "This is a tried and true recipe for Exact Sciences since the launch of Cologuard nearly a decade ago and we have no reason ...

Exact Sciences may have had disappointing Q3 earnings, but its liquidity cushions and new product approval indicate strong ...

TD Cowen analysts said in a note to investors that the third quarter was the third time in five years that Exact Sciences, which sells the Cologuard colorectal cancer screening test, has missed ...

On Monday, Exact Sciences (NASDAQ:EXAS) stock received a reiterated Buy rating and an $82.00 price target from BTIG. The endorsement follows the recent approval by the FDA of Cologuard Plus ...

Puneet Souda’s rating is based on the expectation of broader adoption and higher volumes for Exact Sciences’s Cologuard Plus (CG+), which is anticipated to have higher specificity compared to ...

The biomedical giant best known for its Cologuard at-home colon cancer screening test reported a loss of $38.2 million, or $0.21 per share, on revenue of $708.7 million.

Exact Sciences' Q3 report led to a ~25% drop in share price, due to a slight guidance cut and narrow revenue miss. Learn more ...

Exact Sciences Corp ( (EXAS) ) has released its Q3 earnings. Here is a breakdown of the information Exact Sciences Corp presented to its ...

On Friday, Exact Sciences Corp (NASDAQ:EXAS) maintained its positive outlook from Leerink Partners following the U.S. Food and Drug Administration's (FDA) approval of the company's Cologuard Plus (CG+ ...

What's going on with Exact Sciences? Exact Sciences is best known for Cologuard, its at-home, non-invasive stool test for colorectal cancer. The company has helped screen millions of eligible ...

On Monday, Exact Sciences (NASDAQ:EXAS) stock received a reiterated Buy rating and an $82.00 price target from BTIG. The endorsement follows the recent approval by the FDA of Cologuard Plus, Exact ...